P
LFVN icon

&Partners’s LifeVantage LFVN Stock Holding History

&Partners’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
38,821
+20,259
+109% +$106K ﹤0.01% 2281
2025
Q4 		$114K Sell
18,562
-969
-5% -$7.17K ﹤0.01% 2202
2025
Q3 		$190K Buy
19,531
+1,684
+9% +$21.1K ﹤0.01% 1973
2025
Q2 		$220K Buy
17,847
+481
+3% +$6.22K ﹤0.01% 1787
2025
Q1 		$250K Buy
17,366
+6,773
+64% +$128K ﹤0.01% 1501
2024
Q4 		$188K Buy
+10,593
New +$149K ﹤0.01% 1546

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

&Partners's LFVN Position: Q1 2026 in Review

&Partners increased its LifeVantage (LFVN) stake by 109% in Q1 2026, buying an estimated $106K and bringing the position to 38,821 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

&Partners first reported a position in LFVN in Q4 2024 and has held it in 6 quarters since. The position peaked at $250K in Q1 2025. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • &Partners held 38,821 shares of LifeVantage worth $168K as of Q1 2026.
  • &Partners bought 20,259 LifeVantage shares in Q1 2026, an estimated $106K.
  • LifeVantage made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #2281 holding.
  • &Partners first reported a position in LifeVantage in Q4 2024 and has held it in 6 quarters since.
  • &Partners's LifeVantage position peaked at $250K in Q1 2025.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.